Position in BIIB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$40,387,879
+$14,343,103 QoQ
Shares Held
186,929
+31.6% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#74
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $1,210,256,847 across 11 Drug Manufacturers - General names. BIIB ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
373,768 | $448,308,589 | |
| 2 | JNJ |
Johnson & Johnson
|
1,133,013 | $287,751,311 | |
| 3 | ABBV |
AbbVie Inc.
|
619,181 | $155,810,706 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,301,674 | $132,622,455 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
657,582 | $83,078,909 | |
| 6 | MRK |
Merck & Co., Inc.
|
393,429 | $50,555,626 | |
| 7 | BIIB |
Biogen Inc.
This page
|
186,929 | $40,387,879 | |
| 8 | AMGN |
Amgen Inc
|
18,488 | $6,694,874 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,387,879 | 186,929 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $26,044,776 | 142,065 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $563,695 | 3,203 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $452,598 | 3,231 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $393,347 | 3,132 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $454,171 | 3,319 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $507,541 | 3,319 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,966,700 | 10,146 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,210,635 | 9,536 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,195,852 | 14,821 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,974,707 | 15,360 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $32,319,521 | 125,752 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $58,649,760 | 205,897 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $57,983,434 | 208,551 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $27,525,571 | 99,399 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,609,135 | 103,405 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,613,113 | 96,171 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $40,556,084 | 192,574 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $40,970,418 | 170,767 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $19,311,237 | 68,240 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $24,419,999 | 70,523 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $61,775,514 | 220,824 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $56,035,476 | 228,847 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $57,061,380 | 201,147 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $51,422,307 | 192,197 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $68,276,702 | 215,806 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||